sTREM-1 is a specific biomarker of TREM-1 pathway activation.

Jolly, Lucie;Carrasco, Kévin;Salcedo-Magguilli, Margarita;Garaud, Jean-Jacques;Derive, Marc;et.al.
(2021) Cellular & Molecular Immunology — Vol. 18, n° 8, p. 2054-2056 (2021)

Files

2021_Jolly_Cell_Mol_Immunol.pdf
  • Open Access
  • Adobe PDF
  • 1.17 MB

Details

Authors
  • Jolly, Lucie
    Author
  • Carrasco, Kévin
    Author
  • Salcedo-Magguilli, Margarita
    Author
  • Garaud, Jean-Jacques
    Author
  • Laterre, Pierre-FrançoisUCLouvain
    Author
  • Derive, Marc
    Author
Show more
Abstract
TREM-1 (triggering receptor expressed on myeloid cells-1) is a transmembrane receptor expressed by innate immune cells, including endothelial cells and platelets. TREM-1 is a crucial mediator of septic shock that acts by synergizing with Toll-like receptors (TLRs) to amplify the inflammatory responses to pathogens, thus promoting sepsis-induced immune dysregulation and organ dysfunction. [...]
Affiliations

Citations

Jolly, L., Carrasco, K., Salcedo-Magguilli, M., Garaud, J.-J., Lambden, S., van der Poll, T., Mebazaa, A., Laterre, P.-F., Gibot, S., Boufenzer, A., & Derive, M. (2021). sTREM-1 is a specific biomarker of TREM-1 pathway activation. Cellular & Molecular Immunology, 18(8), 2054-2056. https://doi.org/10.1038/s41423-021-00733-5 (Original work published 2021)